Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renovaro Inc. - Common Stock (NQ: RENB )

0.6340 +0.0703 (+12.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Renovaro Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
From Renovaro Inc
Via GlobeNewswire
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient
From Renovaro Biosciences Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its... 
Via Benzinga
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
WHY: NEW YORK, NY - (NewMediaWire) - February 27, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Renovaro... 
Via TheNewswire.com
ROSEN, A TOP RANKED LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
From The Rosen Law Firm PA
Via GlobeNewswire
Red Flag Alert: 3 Stocks That Hindenburg Research Is Shorting Now
Hindenburg Research's short reports are legendary, and these three companies remain firmly within the activist short-seller's sights. 
Via InvestorPlace
RENOVARO ALERT: Bragar Eagel & Squire, P.C. is Investigating Renovaro Biosciences Inc. on Behalf of Renovaro Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ROSEN, A LEADING LAW FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Renovaro... 
Via TheNewswire.com
RENB SHAREHOLDER ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
From The Rosen Law Firm PA
Via GlobeNewswire
Cutting Edge Blood Genetic Testing Using Nvidia AI Chips Emerging from Acquisition of Dutch Based Cyclomics; Aim to Disrupt Cancer Diagnosis and Treatment: Renovaro Biosciences Inc. (Nasdaq: RENB)
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
From Renovaro Biosciences Inc.
Via GlobeNewswire
Hit With Short Seller Report, Renovaro Biosciences Comments On Hindenburg's Opinion Piece
Renovaro Biosciences confronts Hindenburg's short report fallout, highlighting tech and business leaders joining the board. Despite false claims, the company asserts confidence. 
Via Benzinga
Statement of Renovaro Inc
From Renovaro Biosciences Inc.
Via GlobeNewswire
BioMedNewsBreaks – Renovaro Inc. (NASDAQ: RENB) Fusing AI and Biotech to Accelerate Personalized Medicine, GEDiCube, Cyclomics Enter LOI to ‘Change the Field’
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
ROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
From The Rosen Law Firm, P.A.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Renovaro Biosciences Faces Turmoil After Hindenburg Report Accusing Questionable Merger And Governance, Stock Crashes
Renovaro Biosciences navigates challenges – from a controversial merger with GEDi Cube to allegations of securities law violations. 
Via Benzinga
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance. 
Via Benzinga
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
From Renovaro Biosciences Inc.
Via GlobeNewswire
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
From Renovaro Biosciences Inc.
Via GlobeNewswire
Patients with Swelling Disorder See New Gene Therapy as Godsend
Via Investor Brand Network
Study Explains Why Immunotherapy Could Trigger Colitis in Cancer Patients
Via Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Results of Special Meeting
Via Investor Brand Network
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
From Renovaro Biosciences Inc.
Via GlobeNewswire
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD
Accelerating Healthcare With Award-Winning AI: Big Steps Forward In 2023 And The Early Days Of 2024 
From Renovaro Biosciences Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.